Inventor · disambiguated record
Haitao Ji
Also filed as: JI HAITAO
23 granted patents·14 pending applications·81 citations·filing 2004–2025
93Inventor score
Files withH LEE MOFFITT CANCER CT & RES17UNIV UTAH RES FOUND6INTEL CORP5UNIV NORTHWESTERN4SILVERMAN RICHARD B2
Top patents by PatentIndex Score
37 records- 0192US7994326B2Potent and highly selective heteroaromatic inhibitors of neuronal nitric oxide synthaseUNIV NORTHWESTERN·Filed 2007·Granted Aug 9, 2011·14 cites·20 claims
- 0289US7470790B2Heteroaromatic selective inhibitors of neuronal nitric oxide synthaseUNIV NORTHWESTERN·Filed 2004·Granted Dec 30, 2008·33 cites·10 claims
- 0387US9284299B2Substituted 1H-indazol-1-ol analogs as inhibitors of beta catenin/Tcf protein-protein interactionsUNIV UTAH RES FOUND·Filed 2013·Granted Mar 15, 2016·8 cites·18 claims
- 0486US9090589B2Specific nNOS inhibitors for the therapy and prevention of human melanomaUNIV NORTHWESTERN·Filed 2014·Granted Jul 28, 2015·4 cites·15 claims
- 0586US8557552B2Selective neuronal nitric oxide synthase inhibitorsSILVERMAN RICHARD B·Filed 2012·Granted Oct 15, 2013·10 cites·30 claims
- 0682US11542254B2Methods and composition of 4-substituted benzoylpiperazine-1-substituted carbonyls as beta-catenin/B-cell lymphoma 9 inhibitorsUNIV UTAH RES FOUND·Filed 2017·Granted Jan 3, 2023·2 cites·9 claims
- 0782US8642282B2Inhibitors of nitric oxide synthase for treatment of melanomaMEYSKENS JR FRANK L·Filed 2012·Granted Feb 4, 2014·5 cites·14 claims
- 0881US8158658B2Heteroaromatic selective inhibitors of neuronal nitric oxide synthaseSILVERMAN RICHARD B·Filed 2008·Granted Apr 17, 2012·4 cites·5 claims
- 0976US2025051304A1Beta-catenin and b-cell lymphoma 9 (bcl9) inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 1076US2025115641A1Stapled peptides as pyrin-domain targeted nlrp3 inflammasome inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 1172US12286422B2Methods and compositions of 4-substituted benzoylpiperazine-1-substituted carbonyls as β-catenin/B-cell lymphoma 9 inhibitorsUNIV UTAH RES FOUND·Filed 2022·Granted Apr 29, 2025·0 cites·5 claims
- 1272US12077608B2Stapled H2 pyrin peptidesH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Sep 3, 2024·0 cites·2 claims
- 1372US11905273B2Inhibitors for the B-catenin/B-cell lymphoma 9 (BCL9) protein-protein interactionH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Feb 20, 2024·0 cites·9 claims
- 1468US2022411414A1Inhibitors for the b-catenin/b-cell lymphoma 9 (bcl9) protein-protein interactionH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 1567US12269899B2Peptidomimetic inhibitors of β-catenin/Tcf protein-protein interactionH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Apr 8, 2025·0 cites·18 claims
- 1667US11113159B2Log structure with compressed keysINTEL CORP·Filed 2017·Granted Sep 7, 2021·1 cites·20 claims
- 1767US2025257065A1Small molecule pyrin-domain targeted nlrp3 inflammasome inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2025·Application pending·0 cites
- 1864US12162856B2β-catenin and B-cell lymphoma 9 (BCL9) inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Dec 10, 2024·0 cites·18 claims
- 1963US12319685B2Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jun 3, 2025·0 cites·13 claims
- 2063US2025289848A1Peptidomimetic inhibitors of b-catenin/tcf protein-protein interactionH LEE MOFFITT CANCER CT & RES·Filed 2025·Application pending·0 cites
- 2162US2025019371A1Small-molecular inhibitors for the beta-catenin/ b-cell lymphoma 9 protein-protein interactionH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 2260US11542250B2Inhibitors for the B-catenin/B-cell lymphoma 9 (BCL9) protein-protein interactionH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Jan 3, 2023·0 cites·9 claims
- 2358US11692830B2Real-time localization error correction of autonomous vehicleINTEL CORP·Filed 2020·Granted Jul 4, 2023·0 cites·16 claims
- 2458US2024208940A1Small-molecule inhibitors for beta-catenin/bcell lymphoma 9 protein-protein interactionH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 2557US2021078986A1Inhibitors for the b-catenin/b-cell lymphoma 9 (bcl9) protein-protein interactionH LEE MOFFITT CANCER CT & RES·Filed 2019·Application pending·0 cites
- 2656US12234730B2Underwater robot for mine flooding rescueUNIV ANHUI SCI & TECHNOLOGY·Filed 2024·Granted Feb 25, 2025·0 cites·5 claims
- 2753US2024207458A1Targeted alpha particle therapy for somatostatin receptor 2 positive neuroendocrine tumors and metastasesH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 2852US11530186B2Inhibitors for the β-catenin / T-cell factor protein-protein interactionH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Dec 20, 2022·0 cites·27 claims
- 2952US2022411372A1Small-molecule inhibitors for the b-catenin/b-cell lymphoma 9 protein-protein interactionH LEE MOFFITT CANCER CT & RES·Filed 2020·Application pending·0 cites
- 3050US9738628B2Substituted 1H-indazol-1-OL analogs as inhibitors of beta catenin/Tcf protein-protein interactionsUNIV UTAH RES FOUND·Filed 2016·Granted Aug 22, 2017·0 cites·20 claims
- 3148US12415832B2B-catenin/B-cell Lymphoma 9 protein-protein interaction inhibiting peptidomimeticsUNIV SOUTH FLORIDA·Filed 2020·Granted Sep 16, 2025·0 cites·13 claims
- 3246US11474736B2Network interface controller with non-volatile random access memory write packet logINTEL CORP·Filed 2016·Granted Oct 18, 2022·0 cites·23 claims
- 3346US2022343762A1Quantitative driving evaluation and vehicle safety restrictionsINTEL CORP·Filed 2019·Application pending·0 cites
- 3445US2008176907A1NOS Inhibitors For Treatment Of Motor Deficit DisordersUNIV NORTHWESTERN·Filed 2007·Application pending·0 cites
- 3539US2019310964A1Speculative read mechanism for distributed storage systemINTEL CORP·Filed 2016·Application pending·0 cites
- 3636US2018092866A1Substituted n-([1,1'-biphenyl]-3-yl)-[1,1'-biphenyl]-3-carboxamide analogs as inhibitors for beta-catenin/b-cell lymphoma 9 interactionsUNIV UTAH RES FOUND·Filed 2016·Application pending·0 cites
- 3734US10273246B2Methods and compositions of substituted 5H-[1,2,5] oxadiazolo [3′,4′:5,6] pyrazino[2,3-B] indole analogs as inhibitors of β-catenin/T-cell factor protein-protein interactionsUNIV UTAH RES FOUND·Filed 2016·Granted Apr 30, 2019·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Haitao Ji files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →